Cost and effectiveness of cardiovascular prevention.
Boyar
Alan
A
D002318:Cardiovascular Diseases / Q000191:economics* / Q000517:prevention & control*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics; D008403:Mass Screening / Q000191:economics*; D009203:Myocardial Infarction / Q000191:economics / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011322:Primary Prevention / Q000191:economics; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors